Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.
Financial Results:
Jubilant Pharmova Ltd reported Revenues for Q3FY25 of ₹1,822.00 Crores up from ₹1,677.00 Crore year on year, a rise of 8.65%.
Total Expenses for Q3FY25 of ₹1,682.00 Crores up from ₹1,625.00 Crores year on year, a rise of 3.51%.
Consolidated Net Profit of ₹101.00 Crores up 53.03% from ₹66.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹6.33, up 51.07% from ₹4.19 in the same quarter of the previous year.
![](data:image/svg+xml;charset=utf-8,<svg height="781px" width="640px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
